In a groundbreaking study published in BME Frontiers, researchers from the University of California, Los Angeles (UCLA), in collaboration with ...
The team, which is led from Institut Imagine by Paul Bastard, will receive up to $25m over approximately five years to take on the challenge of cancer avoidance.
The Nation (PK) on MSN
Breast cancer's pathobiology
One disease that arises from disruptions in the cell cycle is cancer. After a series of events, a normal cell begins to divide uncontrollably and becomes a tumour cell. Breast tumours are a complex ...
Bristol Myers Squibb BMY0.60%increase; green up pointing triangle reported higher fourth-quarter revenue as growth in sales of its immuno-oncology treatments helped to offset a decline in revenue for ...
Bristol Myers Squibb reported higher fourth-quarter revenue as growth in sales of its immuno-oncology treatments helped to offset a decline in revenue for some of its older drugs. The company posted ...
Deciduous Therapeutics is developing a novel class of immuno-therapies designed to systemically clear senescent cells and to treat co-morbidities of aging. The gradual accumulation in tissues and ...
GV20 Therapeutics uses its proprietary STEAD (Simultaneous Target Evaluation and Antibody Discovery) platform to decode the natural B cell responses in patient tumors to rapidly identify novel targets ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results